Regenerative Medical Technology Group Inc.
RMTG
$0.09
$0.00-4.44%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.02M | 2.64M | 1.57M | 1.18M | 983.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.02M | 2.64M | 1.57M | 1.18M | 983.30K |
| Cost of Revenue | 1.44M | 872.90K | 792.40K | 679.00K | 397.70K |
| Gross Profit | 2.58M | 1.77M | 779.50K | 501.60K | 585.60K |
| SG&A Expenses | 1.90M | 1.42M | 972.40K | 846.20K | 741.10K |
| Depreciation & Amortization | 90.80K | 97.70K | 98.30K | 76.10K | 54.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.43M | 2.39M | 1.86M | 1.60M | 1.19M |
| Operating Income | 591.00K | 251.30K | -291.30K | -420.80K | -210.30K |
| Income Before Tax | -2.91M | -876.30K | -1.39M | -4.35M | -1.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.91M | -876.30K | -1.39M | -4.35M | -1.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.91M | -876.30K | -1.39M | -4.35M | -1.44M |
| EBIT | 591.00K | 251.30K | -291.30K | -420.80K | -210.30K |
| EBITDA | 681.80K | 349.00K | -192.90K | -344.70K | -155.50K |
| EPS Basic | -0.22 | -0.07 | -0.11 | -0.35 | -0.12 |
| Normalized Basic EPS | -0.14 | -0.04 | -0.07 | -0.20 | -0.07 |
| EPS Diluted | -0.22 | -0.07 | -0.11 | -0.35 | -0.12 |
| Normalized Diluted EPS | -0.14 | -0.04 | -0.07 | -0.20 | -0.07 |
| Average Basic Shares Outstanding | 13.22M | 13.14M | 12.92M | 12.54M | 12.54M |
| Average Diluted Shares Outstanding | 13.22M | 13.14M | 12.92M | 12.54M | 12.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |